Growth Metrics

Veracyte (VCYT) Income from Continuing Operations (2016 - 2025)

Veracyte's Income from Continuing Operations history spans 14 years, with the latest figure at 41197000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 708.89% year-over-year to 41197000.0; the TTM value through Dec 2025 reached 66401000.0, up 175.4%, while the annual FY2025 figure was 66401000.0, 175.59% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 41197000.0 at Veracyte, up from 19137000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 41197000.0 in Q4 2025 and bottomed at 41863000.0 in Q1 2021.
  • The 5-year median for Income from Continuing Operations is 8234000.0 (2023), against an average of 4802350.0.
  • The largest annual shift saw Income from Continuing Operations crashed 632.16% in 2023 before it soared 708.89% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 10468000.0 in 2021, then skyrocketed by 62.99% to 3874000.0 in 2022, then plummeted by 632.16% to 28364000.0 in 2023, then soared by 117.96% to 5093000.0 in 2024, then skyrocketed by 708.89% to 41197000.0 in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Income from Continuing Operations are 41197000.0 (Q4 2025), 19137000.0 (Q3 2025), and 961000.0 (Q2 2025).